Patient Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crocs
CROX
|
+$39M |
| 2 |
Royalty Pharma
RPRX
|
+$34.5M |
| 3 |
Illumina
ILMN
|
+$28.5M |
| 4 |
Seadrill
SDRL
|
+$28.1M |
| 5 |
Peloton Interactive
PTON
|
+$8.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$42.4M |
| 2 |
Ovintiv
OVV
|
+$34.8M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$32M |
| 4 |
DXC Technology
DXC
|
+$25M |
| 5 |
Coinbase
COIN
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.19% |
| 2 | Financials | 25.41% |
| 3 | Communication Services | 11.77% |
| 4 | Energy | 9.22% |
| 5 | Healthcare | 7.54% |
Similar funds
Patient Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Patient Capital Management held 47 positions worth $1.89B, up 11% from $1.7B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Patient Capital Management withdrew a net $58.4M in Q4 2023, closing 4 positions and reducing 23 holdings. Its most notable exit was Splunk Inc, an estimated $42.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 32% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Patient Capital Management opened a new position in Crocs worth $39.4M.
- Patient Capital Management's largest Q4 2023 buy was Crocs: 422,010 shares worth $39.4M.
- Patient Capital Management added most to Peloton Interactive in Q4 2023, an estimated $8.23M increase.
- Patient Capital Management's biggest Q4 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $32M.
- Patient Capital Management fully exited Splunk Inc in Q4 2023, selling an estimated $42.4M.
- Patient Capital Management's ten largest holdings make up 48% of its $1.89B portfolio in Q4 2023.
- Patient Capital Management opened 5 new positions and closed 4 in Q4 2023.
- Patient Capital Management's portfolio value rose 11% quarter-over-quarter to $1.89B.
Based on Patient Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.